Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats
- 4 July 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 307 (3) , 259-267
- https://doi.org/10.1016/0014-2999(96)00270-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensinBrain Research Bulletin, 1995
- Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonistBritish Journal of Pharmacology, 1995
- Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonistBritish Journal of Pharmacology, 1994
- Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the ratBrain Research Bulletin, 1993
- Intracerebroventricular angiotensin II‐induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, Losartan (DuP 753), but not by the AT2 antagonist, CGP 42112BExperimental Physiology, 1992
- Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrierEuropean Journal of Pharmacology, 1992
- Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19European Journal of Pharmacology, 1992
- Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in ratsBrain Research Bulletin, 1991
- Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonistNeuroReport, 1990
- Functions of Angiotensin in the Central Nervous SystemAnnual Review of Physiology, 1987